E. Anthony Jones

11.6k citations

183 papers · 8.7k indexed · 1 hit paper · h-index 52

Impact in

Hepatology top 0.1%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Liver Diseases and Immunity
Pharmacology top 0.2%

Papers in

Hepatology 85
- Liver Disease and Transplantation 46
- Liver Diseases and Immunity 38
Pharmacology 25
- Drug-Induced Hepatotoxicity and Protection 14

Co-authors: Nora V. Bergasa Jay H. Hoofnagle Kevin D. Mullen Anthony S. Basile John Vergalla Daniel F. Schafer Yoon Park Jeanne G. Waggoner
Journals: Gastroenterology (32 papers)Journal of Clinical Investigation (8 papers)European Journal of Gastroenterology & Hepatology (7 papers)Journal of Hepatology (6 papers)Annals of Internal Medicine (5 papers)
Partner nations: United States Netherlands United Kingdom

In The Last Decade

E. Anthony Jones

181 papers receiving 8.2k citations

Hit Papers

align trajectories log scale

Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon 1986 · 740 citations

Peers

Countries citing papers authored by E. Anthony Jones

Since Specialization

Citations

This map shows the geographic impact of E. Anthony Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Anthony Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Anthony Jones more than expected).

Fields of papers citing papers by E. Anthony Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Anthony Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Anthony Jones. The network helps show where E. Anthony Jones may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Anthony Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Anthony Jones Line = papers co-authored together E. Anthony Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cell-type-specific alternative splicing in the brain and kidney of a Setbp1 S858R Schinzel–Giedion syndrome mouse Disease Models & Mechanisms ·ANTHONY E. WALSBY, E. Anthony Jones, Timothy C. Howton, C. Flinterman, Evelyn Fiedler Streng, 竹野佑	2026	0
2	Productivity of laccase in solid substrate fermentation of selected agro-residues by Bioresource Technology ·Vikineswary Sabaratnam, N Abdullah, Marina Compagnucci, Sekaran Muniandy, Ashok Pandey, E. Anthony Jones	2005	83
3	Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions QJM ·E. Anthony Jones	2002	70
4	JAGGED1 expression in human embryos: correlation with the Alagille syndrome phenotype Journal of Medical Genetics ·E. Anthony Jones, (unknown), (unknown)	2000	57
5	Florid opioid withdrawal–like reaction precipitated by naltrexone in a patient with chronic cholestasis Gastroenterology ·E. Anthony Jones, Lukas Dekker	2000	52
6	Pruritus and fatigue in primary biliary cirrhosis Best Practice & Research Clinical Gastroenterology ·Nora V. Bergasa, N. P. SPITSYNA, E. Anthony Jones	2000	59
7	Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study Journal of the American Academy of Dermatology ·Nora V. Bergasa, David W. Alling, Thomas Talbot, Mary C. Wells, E. Anthony Jones	1999	110
8	The effect of flumazenil on visual event-related potentials of clinically non-encephalopathic patients with cirrhosis Neuroscience Letters ·Chao Wang, Dik Reits, E J Grant, E. Anthony Jones, Henk Spekreijse	1999	8
9	Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B e antigen The Lancet ·Frank ter Borg, 地頭園博, Gregory G. Noll, A Leentvaar-Kuijpers, J. Oosting, P. Wertheim‐van Dillen, Pieter Honkoop, Md. Muzharul Hoq, A. Kubilay, Jan van Hattum, T. NAOTA, Linri Cui, E. Anthony Jones	1998	50
10	Resistance to 3-mercaptopropionic acid-induced seizures in hepatic encephalopathy. PubMed ·María del Rosario Ferreira, Sergio H. Gammal, E. Anthony Jones	1997	10
11	Cholestasis in the male rat is associated with naloxone-reversible antinociception Journal of Hepatology ·Nora V. Bergasa, David W. Alling, John Vergalla, E. Anthony Jones	1994	91
12	Increased brain uptake of γ-aminobutyric acid in a rabbit model of hepatic encephalopathy Gastroenterology ·Mark L. Bassett, Kevin D. Mullen, B Scholz, Joseph D. Fenstermacher, E. Anthony Jones	1990	52
13	Flumazenil: Potential implications for hepatic encephalopathy Pharmacology & Therapeutics ·E. Anthony Jones, Anthony S. Basile, Kevin D. Mullen, Sergio H. Gammal	1990	19
14	Intestinal Malabsorption of Vitamin E in Primary Biliary Cirrhosis Gastroenterology ·Ronald J. Sokol, Young S. Kim, Jay H. Hoofnagle, James E. Heubi, E. Anthony Jones, William F. Balistreri	1989	28
15	Effects of Recombinant Human Leukocyte Interferon Treatment on Endogenous Interferon Production in Patients with Chronic Type-B Hepatitis Journal of Interferon Research ·Douglas L. Jicha, Gary L. Davis, Marion G. Peters, Jay H. Hoofnagle, E. Anthony Jones	1986	8
16	Lipoprotein abnormalities in primary biliary cirrhosis Gastroenterology ·C. Jahn, Ernst J. Schaefer, L Taam, Jay H. Hoofnagle, Frank T. Lindgren, John J. Albers, E. Anthony Jones, H Bryan Brewer	1985	41
17	Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. PubMed ·C. Jahn, Ernst J. Schaefer, L Taam, Jay H. Hoofnagle, Frank T. Lindgren, John J. Albers, E. Anthony Jones, H Bryan Brewer	1985	130
18	Alpha‐1‐antitrypsin phenotypes in rheumatoid arthritis and systemic lupus erythematosus Arthritis & Rheumatism ·Jacob Karsh, John Vergalla, E. Anthony Jones	1979	15
19	Receptor Specific Clearance by the Reticuloendothelial System in Chronic Liver Diseases Journal of Clinical Investigation ·Ecse Rensselaer, John M. Vierling, E. Anthony Jones, Thomas J. Lawley, Michael M. Frank	1978	86
20	Serum complement in chronic liver disease Gut ·Barry J. Potter, V Ricciuto, E. Anthony Jones	1973	51

About E. Anthony Jones

E. Anthony Jones is a scholar working on Hepatology, Pharmacology, Cellular and Molecular Neuroscience, Epidemiology and Gastroenterology, having authored 183 papers that have together received 8.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (47 papers), Liver Disease and Transplantation (46 papers), Liver Diseases and Immunity (38 papers), Neuroscience and Neuropharmacology Research (25 papers), Drug Transport and Resistance Mechanisms (18 papers), Epilepsy research and treatment (18 papers), Drug-Induced Hepatotoxicity and Protection (14 papers) and Biochemical effects in animals (12 papers). The work is most often cited by research in Hepatology (4.5k citations), Pharmacology (891 citations), Epidemiology (3.5k citations), Dermatology (642 citations) and Cellular and Molecular Neuroscience (1.0k citations). E. Anthony Jones has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Nora V. Bergasa, Jay H. Hoofnagle, Kevin D. Mullen, Anthony S. Basile, John Vergalla, Daniel F. Schafer, Yoon Park, Jeanne G. Waggoner, Marion G. Peters and Thomas A. Waldmann. Their work appears in journals such as Gastroenterology, Journal of Clinical Investigation, European Journal of Gastroenterology & Hepatology, Journal of Hepatology and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact